Literature DB >> 17999434

Paroxysmal dyskinesias in mice.

Thomas L Shirley1, Lekha M Rao, Ellen J Hess, H A Jinnah.   

Abstract

Animal models of human disease are important tools for revealing the underlying mechanisms of pathophysiology and developing therapeutic strategies. Several unique mouse calcium channel mutants have been identified with nonepileptic, episodic dyskinetic movements that are phenotypically similar to human paroxysmal dyskinesias. In this report, video demonstrations of these motor attacks are provided for two previously described mouse mutants, tottering and lethargic, as well as a new one, rocker. Semiquantitative comparisons using two different rating scales reveal differences in attack morphology, severity, and duration among the strains. These mice provide three independent models of paroxysmal dyskinesia and support for prior proposals that channelopathies may underlie the human disorders. 2007 Movement Disorder Society

Entities:  

Mesh:

Year:  2008        PMID: 17999434      PMCID: PMC2887756          DOI: 10.1002/mds.21829

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  35 in total

Review 1.  Episodic movement disorders as channelopathies.

Authors:  K P Bhatia; R C Griggs; L J Ptácek
Journal:  Mov Disord       Date:  2000-05       Impact factor: 10.338

2.  Ablation of P/Q-type Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)-subunit.

Authors:  K Jun; E S Piedras-Rentería; S M Smith; D B Wheeler; S B Lee; T G Lee; H Chin; M E Adams; R H Scheller; R W Tsien; H S Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 3.  Idiopathic epilepsy and paroxysmal dyskinesia.

Authors:  R Guerrini
Journal:  Epilepsia       Date:  2001       Impact factor: 5.864

4.  Calcium channel agonists and dystonia in the mouse.

Authors:  H A Jinnah; J P Sepkuty; T Ho; S Yitta; T Drew; J D Rothstein; E J Hess
Journal:  Mov Disord       Date:  2000-05       Impact factor: 10.338

5.  Mutation of the Ca2+ channel beta subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (lh) mouse.

Authors:  D L Burgess; J M Jones; M H Meisler; J L Noebels
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

6.  Rocker is a new variant of the voltage-dependent calcium channel gene Cacna1a.

Authors:  T A Zwingman; P E Neumann; J L Noebels; K Herrup
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

7.  Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel.

Authors:  A Jouvenceau; L H Eunson; A Spauschus; V Ramesh; S M Zuberi; D M Kullmann; M G Hanna
Journal:  Lancet       Date:  2001-09-08       Impact factor: 79.321

8.  Motor and cognitive deficits in the heterozygous leaner mouse, a Cav2.1 voltage-gated Ca2+ channel mutant.

Authors:  Isabel Alonso; Joana M Marques; Nuno Sousa; Jorge Sequeiros; I Anna S Olsson; Isabel Silveira
Journal:  Neurobiol Aging       Date:  2007-05-21       Impact factor: 4.673

9.  Triggers of paroxysmal dyskinesia in the calcium channel mouse mutant tottering.

Authors:  Brandy E Fureman; H A Jinnah; Ellen J Hess
Journal:  Pharmacol Biochem Behav       Date:  2002-10       Impact factor: 3.533

10.  Dystonia and cerebellar atrophy in Cacna1a null mice lacking P/Q calcium channel activity.

Authors:  C F Fletcher; A Tottene; V A Lennon; S M Wilson; S J Dubel; R Paylor; D A Hosford; L Tessarollo; M W McEnery; D Pietrobon; N G Copeland; N A Jenkins
Journal:  FASEB J       Date:  2001-05       Impact factor: 5.191

View more
  28 in total

Review 1.  Convergent mechanisms in etiologically-diverse dystonias.

Authors:  Valerie B Thompson; H A Jinnah; Ellen J Hess
Journal:  Expert Opin Ther Targets       Date:  2011-12-03       Impact factor: 6.902

2.  Selective inhibition of striatal fast-spiking interneurons causes dyskinesias.

Authors:  Aryn H Gittis; Daniel K Leventhal; Benjamin A Fensterheim; Jeffrey R Pettibone; Joshua D Berke; Anatol C Kreitzer
Journal:  J Neurosci       Date:  2011-11-02       Impact factor: 6.167

3.  The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia.

Authors:  Karina Alviña; Kamran Khodakhah
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

Review 4.  Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.

Authors:  Esther A R Nibbeling; Cathérine C S Delnooz; Tom J de Koning; Richard J Sinke; Hyder A Jinnah; Marina A J Tijssen; Dineke S Verbeek
Journal:  Neurosci Biobehav Rev       Date:  2017-01-28       Impact factor: 8.989

5.  Purkinje cell input to cerebellar nuclei in tottering: ultrastructure and physiology.

Authors:  Freek E Hoebeek; Sara Khosrovani; Laurens Witter; Chris I De Zeeuw
Journal:  Cerebellum       Date:  2008-12-11       Impact factor: 3.847

6.  Subtle microstructural changes of the cerebellum in a knock-in mouse model of DYT1 dystonia.

Authors:  Chang-Hyun Song; Doug Bernhard; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2013-10-11       Impact factor: 5.996

Review 7.  The functional neuroanatomy of dystonia.

Authors:  Vladimir K Neychev; Robert E Gross; Stephane Lehéricy; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2011-02-12       Impact factor: 5.996

8.  Flocculus Purkinje cell signals in mouse Cacna1a calcium channel mutants of escalating severity: an investigation of the role of firing irregularity in ataxia.

Authors:  John S Stahl; Zachary C Thumser
Journal:  J Neurophysiol       Date:  2014-08-20       Impact factor: 2.714

9.  The basal ganglia and cerebellum interact in the expression of dystonic movement.

Authors:  Vladimir K Neychev; Xueliang Fan; V I Mitev; Ellen J Hess; H A Jinnah
Journal:  Brain       Date:  2008-07-26       Impact factor: 13.501

10.  Kinematic and electromyographic tools for characterizing movement disorders in mice.

Authors:  Hans C Scholle; H A Jinnah; Dirk Arnold; Frank H W Biedermann; Bernd Faenger; Roland Grassme; Ellen J Hess; Nikolaus P Schumann
Journal:  Mov Disord       Date:  2010-02-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.